Zearup Biomed Bio
Zearup Biomed is developing an innovative microneedle patch to prevent dangerously low blood sugar in people with diabetes. The patch releases glucagon, a natural hormone that raises blood sugar, only when glucose levels drop too low. This smart, painless patch aims to make diabetes management safer and easier. Based in Toronto, Zearup Biomed builds on strong research in glucose-responsive materials and microneedle technology to bring this breakthrough toward real-world use.
Contact: zearupbiomed@gmail.com